Metis Precision Medicine
Description: Metis Precision Medicine develops anti-Met mAbs for cancer therapy, seeking investors or partners to globalize its platform tech.
Country: Italy
Based in: Turin
Founded: 2017
Funding Stage: Seed
Tags: ['Biotechnology', 'Health Care', 'Pharmaceutical']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
